Research Summary
ADHD or Attention Deficit Hyperactivity Disorder is a neurological disorder that affects both children and adults. It is characterized by problems with impulse control, hyperactivity and difficulty paying attention. The most commonly used medication to treat ADHD is stimulants, such as Methylphenidate (Ritalin) or Amphetamines (Adderall). These drugs work by increasing the levels of the neurotransmitters dopamine and norepinephrine in the brain, which leads to improved focus, attention and impulse control. Non-stimulant medications like Atomoxetine (Strattera) and Guanfacine (Intuniv) are also used to treat ADHD. These drugs work by affecting other neurotransmitters like norepinephrine and acetylcholine in the brain, leading to improved attention and impulse control. Treatment for ADHD is decided based on the individual's symptoms, severity of the condition, and response to medication. However, medication must be given only under the supervision of a healthcare provider.
According to DIResearch's in-depth investigation and research, the global Attention Deficit Hyperactivity Disorder (ADHD)Drug market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Attention Deficit Hyperactivity Disorder (ADHD)Drug include Eli Lilly, Novartis, Takeda, Pfizer, GlaxoSmithKline, Mallinckrodt, Hisamitsu, Johnson & Johnson, Purdue Parma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Attention Deficit Hyperactivity Disorder (ADHD)Drug. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Attention Deficit Hyperactivity Disorder (ADHD)Drug market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Attention Deficit Hyperactivity Disorder (ADHD)Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Attention Deficit Hyperactivity Disorder (ADHD)Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Attention Deficit Hyperactivity Disorder (ADHD)Drug Include:
Eli Lilly
Novartis
Takeda
Pfizer
GlaxoSmithKline
Mallinckrodt
Hisamitsu
Johnson & Johnson
Purdue Parma
Attention Deficit Hyperactivity Disorder (ADHD)Drug Product Segment Include:
Stimulants Drugs
Non-stimulants Drugs
Attention Deficit Hyperactivity Disorder (ADHD)Drug Product Application Include:
Pediatric
Adolescent
Adults
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Industry PESTEL Analysis
Chapter 3: Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Industry Porter's Five Forces Analysis
Chapter 4: Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Major Regional Market Size and Forecast Analysis
Chapter 5: Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Attention Deficit Hyperactivity Disorder (ADHD)Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Attention Deficit Hyperactivity Disorder (ADHD)Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Attention Deficit Hyperactivity Disorder (ADHD)Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Attention Deficit Hyperactivity Disorder (ADHD)Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Attention Deficit Hyperactivity Disorder (ADHD)Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD)Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Overview 1.1 Product Definition and Statistical Scope 1.2 Attention Deficit Hyperactivity Disorder (ADHD)Drug Product by Type 1.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Stimulants Drugs 1.2.3 Non-stimulants Drugs 1.3 Attention Deficit Hyperactivity Disorder (ADHD)Drug Product by Application 1.3.1 Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Pediatric 1.3.3 Adolescent 1.3.4 Adults 1.4 Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Revenue Analysis (2019-2030) 1.5 Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Development Status and Trends 1.5.1 Attention Deficit Hyperactivity Disorder (ADHD)Drug Industry Development Status Analysis 1.5.2 Attention Deficit Hyperactivity Disorder (ADHD)Drug Industry Development Trends Analysis 2 Attention Deficit Hyperactivity Disorder (ADHD)Drug Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Analysis by Regions 4.1 Attention Deficit Hyperactivity Disorder (ADHD)Drug Overall Market: 2023 VS 2024 VS 2030 4.2 Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Revenue and Market Share by Region (2019-2024) 4.2.2 Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Revenue Forecast by Region (2025-2030) 5 Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Type and Application 5.1 Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Type 5.2 Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Application 6 North America 6.1 North America Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Type 6.4 North America Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Application 6.5 North America Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Type 7.4 Europe Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Application 7.5 Europe Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Type 8.4 China Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Type 9.4 APAC (excl. China) Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Application 9.5 APAC (excl. China) Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Type 10.4 Latin America Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Application 10.5 Latin America Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Type 11.4 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Application 11.5 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Revenue by Key Manufacturers (2020-2024) 12.2 Attention Deficit Hyperactivity Disorder (ADHD)Drug Competitive Landscape Analysis and Market Dynamic 12.2.1 Attention Deficit Hyperactivity Disorder (ADHD)Drug Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Eli Lilly 13.1.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD)Drug Product Portfolio 13.1.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Novartis 13.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Novartis Attention Deficit Hyperactivity Disorder (ADHD)Drug Product Portfolio 13.2.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Takeda 13.3.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Takeda Attention Deficit Hyperactivity Disorder (ADHD)Drug Product Portfolio 13.3.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Pfizer 13.4.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Pfizer Attention Deficit Hyperactivity Disorder (ADHD)Drug Product Portfolio 13.4.3 Pfizer Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 GlaxoSmithKline 13.5.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 GlaxoSmithKline Attention Deficit Hyperactivity Disorder (ADHD)Drug Product Portfolio 13.5.3 GlaxoSmithKline Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Mallinckrodt 13.6.1 Mallinckrodt Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD)Drug Product Portfolio 13.6.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Hisamitsu 13.7.1 Hisamitsu Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Hisamitsu Attention Deficit Hyperactivity Disorder (ADHD)Drug Product Portfolio 13.7.3 Hisamitsu Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Johnson & Johnson 13.8.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD)Drug Product Portfolio 13.8.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Purdue Parma 13.9.1 Purdue Parma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD)Drug Product Portfolio 13.9.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD)Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Attention Deficit Hyperactivity Disorder (ADHD)Drug Industry Chain Analysis 14.2 Attention Deficit Hyperactivity Disorder (ADHD)Drug Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Attention Deficit Hyperactivity Disorder (ADHD)Drug Typical Downstream Customers 14.4 Attention Deficit Hyperactivity Disorder (ADHD)Drug Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support